Trials / Recruiting
RecruitingNCT06221800
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
A Pilot Study to Assess the Diversity of Gut Microbiome in Metastatic Non-Small Cell Lung Cancer (NSCLC) in Correlation to Treatment Effects and Adverse Effects
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (estimated)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study collecting data on the diversity and composition of gut microbiomes in subjects with advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) while receiving treatment for NSCLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Microbiome | Stool and saliva samples will be collected |
Timeline
- Start date
- 2024-01-31
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-01-24
- Last updated
- 2026-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06221800. Inclusion in this directory is not an endorsement.